Skip to main content

Find Clinical Trials

Home
Conditions
Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant

Clinical trial condition

Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant

Explore clinical trials studying Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant trial results

Recruiting

Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors

NCT06914479

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +8 more
Locations: University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States

View Trial Details